FDA qualifies biomarker in controlled malaria infection trials - UW Medicine Newsroom
FDA qualifies biomarker in controlled malaria infection trials UW Medicine Newsroom
A molecular test, proven more effective than thick blood smears at detecting malaria parasites earlier in an infection, has now received Food and Drug ...
Comments
Post a Comment